Combine RNAseq and scRNAseq data with other omics data types (e.g., genomics, proteomics) using ML/DL to provide a comprehensive understanding of the molecular drivers of cancer. a) Precision medicine b) Systems biology c) Epidemiology d) Pharmacogenomics